Ming Li

Dr. Ming Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
ZZZhongsu Zhou
Zhongsu Zhou
SHShuangze Han
Shuangze Han
JLJinzhuang Liao
Jinzhuang Liao
RWRuirui Wang
Ruirui Wang
XYXinfang Yu
Xinfang Yu
MLMing Li
Ming Li

1 January 2023 in Journal of Cancer
Verified
Journal Article
Open access
PDF file
SHShuangze Han
Shuangze Han
XYXinfang Yu
Xinfang Yu
RWRuirui Wang
Ruirui Wang
XWXiaocong Wang
Xiaocong Wang
LLLu Lu Liu
Lu Lu Liu
ZZZhong Su Zhou
Zhong Su Zhou
Apoptosis alteration is responsible for tumorigenesis and tumor resistance to therapies. The natural product Tanshinone IIA (Tan IIA) exhibits potent inhibitory effects against various tumors. However, the effect of Tan IIA on apoptosis and its underlying mechanism remains elusive in oral squamous cell carcinoma (OSCC). Here, we demonstrated that Tan IIA dose-dependently suppressed cell viability and colony formation in CAL27, SCC4, and SCC25 cells. Moreover, Tan IIA inhibited Akt activation from inducing Foxo3a dephosphorylation and PUMA-mediated apoptosis. PUMA or Foxo3a knockdown compromised the inhibitory effect of Tan IIA on OSCC cells. Tan IIA administration inhibited CAL27-deprived xenograft tumor growth and increased PUMA expression in vivo. Tan IIA synergistically intensified the efficacy of CDDP/5-FU-based chemotherapy on OSCC cells. Overall, our results revealed that Tan IIA exerted potent antitumor effects via promoting PUMA-mediated apoptosis in OSCC cells.

1 January 2025 in Journal of Cancer
Verified
Journal Article
Open access
PDF file
JFJinglin Fang
Jinglin Fang
RWRuirui Wang
Ruirui Wang
XLXiaoying Li
Xiaoying Li
XWXiao Cong Wang
Xiao Cong Wang
LGLingling Gong
Lingling Gong
MLMing Li
Ming Li
Dioscin is a natural plant-derived steroidal saponin that exerts antitumor effects in multiple cancers. It is widely involved in multiple apoptotic pathways and exerts its anti-tumor effects. In this study, we discovered that Dioscin treatment increased the expression of Noxa, thereby inducing the apoptosis of OSCC cells. Previous reports indicate that dysfunction of the BMI1-Noxa axis is frequently observed in multiple cancers. Our study revealed that Dioscin upregulates Noxa by impairing the protein expression of BMI1 in OSCC cells. Dioscin promotes the ubiquitination of BMI1 and facilitates its degradation, leading to upregulation of Noxa expression at the mRNA level and activation of apoptosis. Additionally, Dioscin exhibited potent tumor suppression in xenograft tumor models. In conclusion, our research provides new insights and strategies for inhibiting OSCC cells by investigating the ant-tumor mechanism of the natural compound Dioscin.

26 September 2025 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
ALAn Lou
An Lou
XZXuan Zhu
Xuan Zhu
HPHongtai Pei
Hongtai Pei
JZJing Zhou
Jing Zhou
MLMing Li
Ming Li
This study aims to enhance the current clinical understanding of prophylactic antibiotic treatment in China before implant surgeries, and improve the experience and adherence of patients who undergo implant procedures. Patients eligible for inclusion in the past six years were divided into two groups of 500 patients each. Patients in the medication group received one 500 mg cefixime tablet and one 500 mg ornidazole tablet 0.5 hours before implantation. Patients in the non-medicated group did not receive any medicine. Patients were evaluated at two follow-ups: 7–14 days and 3–6 months after implant surgeries. The primary outcome was implant failure, which was characterized as implant detachment or complete loss during follow-ups, implant mobility (clinical mobility >1 mm) detected by surgeons when manually tightening abutments at the second follow-up (3–6 months after surgeries), or complications requiring clinical intervention occurred, including peri-implant bone resorption exceeding acceptable levels. Secondary outcomes were postoperative infection and adverse events. We statistically analyzed study outcomes using the Pearson Chi-square test, Fisher's exact test, and a multiple logistic regression model to evaluate differences between the two groups. P values less than 0.05 or 95% confidence intervals of relative risk or odds ratio values excluding one were considered statistically significant. We noted implant failures (medication group: four patients, 0.8% and non-medicated group: three patients, 0.6%) and postoperative infections (medication group: 23 patients, 4.6% and non-medicated group: 25 patients, 5.0%) were no statistically significant difference between the two groups. However, adverse events showed a statistically significant increase in the medication group (medication group: 111 patients, 22.2% and non-medicated group: 21 patients, 4.2%), including nausea, vomiting, hypersomnia, dizziness, and diarrhea. There was a statistically non-significant increase in fever in the non-medicated group. No statistically significant evidence existed in preventing postoperative infection between the two groups across smoking status, age, implant system, number of implants (1, 2–3, and ≥4), sinus elevation surgery, implant placement, and guided bone regeneration surgery. Antibiotic prophylaxis using ornidazole in conjunction with cefixime in implant surgery may not have clinical benefits but significantly increases adverse events. Therefore, the necessity of prophylactic antibiotic use in healthy patients before implant surgeries needs to be reconsidered.

10 October 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
ALAn Lou
An Lou
JZJing Zhou
Jing Zhou
MSMingze Sun
Mingze Sun
ZLZheming Li
Zheming Li
BZBoran Zhang
Boran Zhang
MLMing Li
Ming Li
This case report details the management of dental complications in an 11-year-old male diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA),

30 April 2026 in Research Square
Verified
Preprint
Open access
PDF file
TXTing Xiao
Ting Xiao
YMYanjun Ma
Yanjun Ma
ZYZhenyu Yang
Zhenyu Yang
ZXZi Xiang
Zi Xiang
LGLingling Gong
Lingling Gong
MLMing Li
Ming Li
Background The Chinese government implemented the National Centralized Dental Implants Procurement (NCDIP) policy in September 2022 to enhance the accessibility and quality of dental services and to support the sustainable development of the dental implant industry. In this study, dentists’ knowledge, attitudes, and practices (KAP) regarding the NCDIP were assessed; the implementation of the policy was evaluated; factors influencing KAP were identified; and recommendations were proposed to inform policy refinement and enforcement. Methods A cross-sectional study was conducted in China between May and June 2023 to assess licensed dentists’ knowledge, attitudes, and practices regarding the NCDIP policy using an online survey. Logistic regression analyses were performed to identify factors associated with dentists’ KAP. Results A total of 1,153 dentists completed the survey. Overall, 97.79% of respondents reported awareness of the NCDIP policy, and 71.18% reported being familiar with it. Female dentists demonstrated a higher level of understanding of the policy than male dentists. Among respondents, 79.53% believed that the NCDIP policy could influence healthcare reform, and 75.04% agreed that its implementation was reasonable and could reduce the cost of dental implants. Additionally, 69.32% of dentists believed that the policy could reduce the economic burden on patients, with dentists working in private hospitals reporting stronger perceptions of the policy's impact. Regarding practice, 88.2% of dentists reported prioritizing centrally procured implants, 90.8% reported actively seeking information about the policy, and 90.8% reported actively promoting the policy to patients. Furthermore, 80.14% indicated that they or their family members would choose implants procured through national centralized purchasing. Higher educational attainment was associated with a greater likelihood of choosing centralized procurement, while employment in private hospitals was associated with increased willingness to learn about and promote the policy. Conclusions Overall, most dentists demonstrated adequate understanding of and support for the NCDIP policy; however, further efforts are required to strengthen its promotion and enforcement, particularly in public hospitals, to ensure consistent adherence.